1E Therapeutics (1Etx) is a breakthrough drug development company creating first-in-class RNA-targeting therapeutics based on our proprietary drug design platform. 1E is the culmination of years of innovation, effort, and tens of millions of $US investment in research and development. 1E's proprietary and groundbreaking rapid drug design process has proven uniquely able to develop innovative drugs that address chronic life threatening indications as well as emerging and evolving pathogens. 1E already has lead compounds that address a wide array of indications in oncology, age-related diseases, anti-microbial resistance, and neurological disorders.
View Top Employees from 1E TherapeuticsWebsite | http://www.1etx.com |
Employees | 44 (37 on RocketReach) |
Founded | 2020 |
Industry | Pharmaceutical Manufacturing |
Looking for a particular 1E Therapeutics employee's phone or email?
Joel Kaye is the Senior Vice President Nonclinical Development of 1E Therapeutics.
37 people are employed at 1E Therapeutics.
1E Therapeutics is based in Rehovot, Center District.